The potential neuroprotection of nicotinamide on the consequences of perinatal asphyxia was investigated with triple organotypic cultures. Perinatal asphyxia was induced in vivo by immersing foetuses-containing uterine horns removed from ready-to-deliver rats into a water bath for 20 min. Sibling caesarean-delivered pups were used as controls. Three days later tissue from substantia nigra, neostriatum and neocortex was dissected and placed on a coverslip.
After a month, the cultures were processed for immunocytochemistry and phenotyped with markers against the NMDA receptor subunit NR1, tyrosine hydroxylase (TH), or neuronal nitric oxide synthase (nNOS). Some cultures were analysed for cell viability. Nicotinamide (0.8 mmol/kg, i.p.) or saline was administered to asphyxia-exposed and caesarean-delivered control pups 24, 48 and 72 h after birth. Perinatal asphyxia produced a decrease of cell viability in substantia nigra, but not in neostriatum or neocortex. Immunocytochemistry conWrmed the vulnerability of the substantia nigra, demonstrating that there was a signiWcant decrease in the number of NR1 and TH-positive (+) cells/mm 2 , as well as a decrease in the length of TH + processes, suggesting neurite atrophy. In control cultures, many nNOS + cells were seen, with diVerent features, regional distribution and cell body sizes. Following perinatal asphyxia, there was an increase in the number of nNOS + cells/mm 2 in substantia nigra, versus a decrease in neostriatum including reduced neurite length, and no apparent changes in neocortex. The main eVect of nicotinamide was seen in the neostriatum, preventing the asphyxia-induced decrease in the number of nNOS + cells and neurite length. Nicotinamide also prevented the eVect of perinatal asphyxia on TH-positive neurite length. The present results support the idea that nicotinamide can prevent the eVects produced by a sustained energy-failure condition, as occurring during perinatal asphyxia.
Introduction
Asphyxia interrupts oxygen availability, resulting in increased anaerobic metabolism, decreased production of energy-rich phosphate compounds, and interruption of membrane conductance. When sustained, the insult can threaten DNA integrity (Kihara et al. 1994; Akhter et al. 2001) , triggering a cascade of events buVering the menace to the stability of the genome, notably the immediate activation of poly(ADP-ribose) polymerase-1 (PARP-1) and PARP-2, which are members of a large family of PARPs (Amé and Spenlehauer de Murcia 2004) .
When DNA damage is mild, PARP-1 is involved in the maintenance of chromatin integrity, by signalling cell-cycle arrest and by reacting with DNA repairing enzymes, such as X-ray cross complementing factor 1 (XRCC1) (Green et al. 1992 ) and DNA-dependent protein kinase (de Murcia and Menissier de Murcia 1994) . Severe perinatal asphyxia produces DNA breaks (Kihara et al. 1994) , and increases the expression of the XRCC1 and excision repair cross-complementing rodent repair group 2 (ERCC2) (Chiappe-Gutierrez et al. 1998) genes. Like XRCC1, ERCC2 is involved in repairing DNA damage (Sung et al. 1993 ). When DNA is damaged, PARP-1 is over-activated (Berger 1985) , resulting in NAD + exhaustion and energy crisis (Ying et al. 2005) , leading to a caspase-independent apoptosis, via translocation of the mitochondrial pro-apoptotic protein, Apoptosis-inducing factor (AIF). PARP-1 is involved in the regulation of cell proliferation and diVerentiation, and may modulate the transcription of several inXammatory signals, including nuclear factor B (NF-B) (Hassa and Hottinger 1999) . It has been suggested that PARP-1 modulates nitric oxide (NO) synthesis, via inducible NO synthase (iNOS), but also via the neuronal isoform of NOS (nNOS) (Hwang et al. 2002; Mishra et al. 2003; Hortobagyi et al. 2003) . Hence, PARP-1 inhibition has emerged as the main target for neuroprotection following hypoxic or ischemic insults (see Virag and Szabo 2002) .
There is also evidence that PARP inhibition can be deleterious, depending upon the level of NAD + cellular content. In the presence of NAD + , PARP inhibition sensitises cells to DNA damage, increasing cell death (Nagayama et al. 2000) , and apoptosis (Saldeen and Welsh 1998) in rapidly dividing cells, perhaps by blocking the access of DNA to replication or repair enzymes, promoting G2 arrest followed by p53-independent apoptosis (Saldeen et al. 2003) , resulting in inhibition of cell proliferation.
Nicotinamide has been proposed to protect against oxidative stress produced by hypoxia or ischemia in neonatal rat brain, by replacing NADH or NAD + (Zhang et al. 1995) . We have reported that neonatal treatment with nicotinamide prevents several deWcits in monoamine levels induced by perinatal asphyxia , including dopamine release monitored with in vivo microdialysis 3 months after birth , supporting the idea that nicotinamide can constitute a therapeutic strategy against the long-term deleterious consequences of perinatal asphyxia, as already proposed for several other pathophysiological conditions (see Virag and Szabo 2002) .
In this paper, we focus on the eVect of nicotinamide on basal ganglia neurocircuitries studied in organotypic cultures, a model originally developed by Gähwiler (1981) , extensively validated by Plenz and Kitai (1996a, b; Plenz et al. 1998) , and used for the reconstruction of the neurocircuitries of the basal ganglia (GomezUrquijo et al. 1999 ). The neuronal phenotype was assessed with markers against: (1) the N-methyl-Daspartate (NMDA) receptor subunit 1 (NR1); (2) tyrosine hydroxylase (TH), the rate-limiting enzyme of dopamine (DA) synthesis, and (3) nNOS.
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As previously reported (Morales et al. 2003; Klawitter et al. 2005) , perinatal asphyxia produces regionally speciWc neuronal decrease and neurite atrophy in basal ganglia, reconstructed with organotypic cultures. We report here that several of these changes can be reversed by treating the animals with nicotinamide before the explanting procedure. A preliminary version of this work has been published elsewhere (Klawitter et al. 2006) .
Experimental procedures

Perinatal asphyxia
Pregnant Wistar rats (UChA, bred at a local colony) were anaesthetised with isoXurane USP (Baxter Healthcare Corp, Guayama, Puerto Rico) within the last day of gestation (G 22) and euthanized by neck dislocation followed by hysterectomy. One or two pups were removed immediately and used as non-asphyxiated caesarean-delivered controls, and the uterine horns containing the remaining foetuses were immersed in a water bath at 37°C for 20 min. Following asphyxia, the uterine horns were incised and the pups were removed, and stimulated to breathe. After a 60 min observation period, the pups were given to surrogate dams for nursing, pending further experiments. Three days after birth (P3), the pups were used for preparing organotypic cultures (Morales et al. 2003; Klawitter et al. 2005) .
The survival rate produced by severe asphyxia (>20 min, at 37°C) was approximately 50% (HerreraMarschitz et al. 1993 ; see Bustamante et al. 2006) . Each mother had to produce animals for: (1) saline-treated, caesarean-delivered (CS); (2) nicotinamide-treated, caesarean-delivered (CN); (3) saline-treated, asphyxiaexposed (AS), and (4) nicotinamide-treated, asphyxiaexposed (AN) groups. Control and treated pups (P3) were killed pair-wise for preparing organotypic cultures. The number of substantia nigra pieces (approximately four per pup) being the limiting factor for the quantity of cultures per animals. Thus, considering a 50% success rate, each animal provided two organotypic cultures. Coronal sections were cut with a microslicer (DTK-2000, Dosaka CO, Japan) at mesencephalic (300 m thick) and telencephalic (350 m thick) levels in cold DMEM. Samples from substantia nigra, neostriatum and neocortex (frontoparietal cortex) were dissected using the atlas by Foster (1998) as a reference. The dissected tissue was placed on a coverslip (Nunc Thermanox Coverslips; Nunc, Naperville, IL, USA) containing a spread layer of chicken plasma (25 l), and further coagulated by bovine thrombin (20 l, 1,000 NIH units in 0.28 ml DMEM; Sigma). The coverslips were then transferred to sterile Nunc Xat CT-tubes (Nunc), containing an un-buVered culture medium (50% Basal Medium Eagle; 25% Hanks Balanced Salt Solution, and 25% horse serum (Gibco BRL), 0.5% glucose (Sigma), 0.5 mM of L-glutamine (Sigma), and 0.1% antibiotic or antimycotic (Gibco BRL).
The cultures were grown at 35°C, 10% CO 2 in a Cell Incubator (Model TC2323, ShelLab, Oregon, USA), with a Roller device exposing the cultures to gaseous or water phases every minute. At 3 days in vitro (DIV), 10 l of a mitosis inhibitor cocktail (4.4 mM cytosine--D-arabinofuranoside, 4.4 mM uridine and 4.4 mM 5-Xuoro-2Ј-deoxyuridine; all from Sigma) was added for 24 h in order to decrease glial proliferation. The medium was changed every 3-4 days.
In vitro and ex vivo monitoring Growth was periodically monitored with an inverted microscope equipped with HoVmann optic (Nikon T100). Pictures were regularly taken, and at DIV 25 the cultures were Wxed with a formalin solution. Alternatively, the cultures were analysed for cell viability at DIV 27, with the LIVE/DEAD ® Viability/Citotoxicity kit L3224 (Molecular Probes, Eugene, OR, USA), using ethidium-homodimer (EthD-1) and calcein-acetoxymethyl ester (AM) for labelling dead and alive cells, respectively. For quantiWcation three samples were taken from the core and border of the tissue, focusing on areas presenting the majority of EthD-1 positive cells (see Fig. 1a-f ).
Immunocytochemistry
The cultures were Wxed in formalin (4% para-formaldehyde, PF; Sigma, in 0.1 M of phosphate-buVered saline, PBS, pH 7.4) at »DIV 25. After rinsing cycles, endogenous peroxidase activity was blocked with 1% H 2 O 2 for 30 min and rinsed again with PBS. The tissue was then preincubated with 2% of bovine serum albumin (BSA) (Calbiochem, CA, USA), 0.3% Triton X-100, in PBS, for 1 h at 37°C, and incubated for 72 h with a mouse monoclonal antibody against NR1 (dilution 1:600; 2% BSA and 0.3% Triton X-100, in PBS) (Pharmingen, San Diego, CA, USA) in order to characterise a general neuronal phenotype (Petralia et al. 1994) . For visualizing TH, the slices were incubated overnight with mouse monoclonal antibody (1:300; 2% BSA and 0.3% Triton X-100, in PBS) (Diasorin, Stillwater, MN, USA). For nNOS, the slices were incubated for 24 h with a sheep monoclonal antibody (1:500, 1% BSA, PBS/0.6% Triton X-100) (generously donated by Prof. P. Emson). After rinsing, the slices were processed using a Vectastain Elite ABC kit (Vector Laboratories, Burlingame, CA, USA), according to the instructions of the manufacturer, visualizing the reaction with Vector Nova Red (Vector Laboratories). Otherwise, the slices were processed with a streptavidin phosphatase complex for 1 h, rinsed and incubated with a levamisole solution for 15 min to inhibit endogenous alkaline phosphatases. The reaction was then visualised with a 5-bromo-4-chloro-3-indolyl phosphate/ nitroblue tetrazolium (BCIP/NBT) substrate kit (Vector Laboratories). The sections were dehydrated through graded alcohols, cleared in xylene and coverslipped in Entellan mounting medium (Merck, Darmstadt, Germany).
QuantiWcation
QuantiWcation was performed directly on the stage of a microscope using appropriate objectives and Wlters for the corresponding markers (NR1, TH or nNOS), or on pictures taken at 20X primary magniWcation. The microphotographs were digitally stored, composed and analysed with Adobe Photoshop (7.0). Positive cells were quantiWed in 1 mm 2 samples using a graded ocular, selecting three areas from the core of each culture showing the largest number of positive cells (see inserts in Figs. 1, 3 ). This selection was required, because the orga- open bars, n = 16), saline-treated, asphyxia-exposed (AS; Wlled bars, n = 17) and nicotinamide-treated, asphyxia-exposed (AN; hatched bars, n = 10) rats. Multiple comparison analysis (Kruskal-Wallis's ANOVA, H) revealed signiWcant diVerences between groups (H = 43.75; m,n = 3,30), allowing post-hoc comparisons, demonstrating a signiWcant increase of EthD-1 + cells in SN of cultures from AS and AN, compared to CS animals. No diVerences were found in Str and Cx. The insert illustrates microphotographs of the sampling procedure in cultures from salinetreated, caesarean-delivered (a-c), and asphyxia-exposed (d-f) animals (cell viability test, Molecular Probes L3224). For each test, three 1 mm 2 samples were selected from substantia nigra (a, d), neostriatum (b, f) and neocortex (c, e), in the areas showing the largest number of EthD-1+ cells. The data are means § SEM; *P < 0.05 (Dunn's test, as a post-hoc test). Scale bar = 500 m notypic cultures are not always characterised by a uniform tissue layer, but part of the issue can sometimes be interrupted by holes, or debris from the culturing procedure. Three parameters were quantiWed: (1) number of positive cells/mm 2 ; (2) soma size (diameter, m), and (3) neurite length (maximum length, m). The measurement of neurite length was restricted to the corresponding tissue, substantia nigra, neostriatum or neocortex. The same parameters were measured pair wise by an investigator blinded to the codes of the culture, explanted from any of the following experimental groups: (1) CS; (2) CN; (3) AS, or (4) AN animals. The values were transferred to an EXCEL matrix for the corresponding quantitative analysis. All data are expressed as means § SEM. Multiple comparisons were tested with the ANOVA (H) of Kruskal-Wallis, followed by a post-hoc test when required (GraphPad Prism; version 4.0, 2003; San Diego, CA, USA), using a level of P < 0.05 as a limit for statistical signiWcance.
Results
Some cultures (CS, AS, AN) were preserved for cell viability test performed at 27 DIV with the LIVE/DEAD ® kit, using Calcein-AM (green Xuorescence) and EthD-1 (red Xuorescence) for labelling alive and dying cells, respectively. The individual regions were well outlined by a strong green Xuorescence, revealing a core with plenty of alive cells. Some red cells could be seen in the core of the tissue, but many more were seen in the gaps between the individual structures.
For quantiWcation, three 1 mm 2 areas per structure were selected, trying to cover the areas with the largest density of cells (the insert in Fig. 1 exempliWes the sampling procedure). EThD-1 positive (+) cells seen in the gaps between individual tissues or in holes were not quantiWed. The quantitative analysis (Fig. 1) revealed a marked increase of EThD-1 + cells in substantia nigra of cultures from AS (»39%) (Wlled bars, n = 17) and AN (»37%) (hatched bars, n = 10), compared to CS (open bars, n = 16) animals (H = 43; m,n = 3,30) . No diVerences were detected in neostriatal or neocortical tissue of cultures from saline-or nicotinamide-treated, asphyxia-exposed, compared to control animals ( Fig. 1) . Some few CN samples were also assayed for cell viability, but no apparent diVerences were observed; hence reserving the material and giving priority for immunocytochemistry investigating the neuronal phenotype.
The cultures were routinely Wxed at 25 DIV and treated for immunocytochemistry. Figure 2 shows microphotographs of neurons and processes labelled with an antibody against NR1 in cultures from CS (a,b,c), AS (d,e,f), and AN (g,h,i) animals, in substantia nigra (SN), Quantitative analysis was applied for cultures from CS (n = 9-12), CN (n = 6), AS (n = 15-17) and AN (n = 9-10) animals. Three samples of 1 mm 2 of area for each region (see insert, Fig. 3 ) were analysed for: (1) number of neurons (NR1 + cells/mm 2 ); (2) size of soma ( m), and (3) maximal neurite length ( m). Neurite length was estimated in the corresponding region, as long as the NR1 staining could be followed at 40-100X. Multiple comparison analysis revealed signiWcant diVerences between groups for cell number and soma size (H = 39.31; H = 47.2, m,n = 4,24, respectively), but not for neurite length (H = 7.9, m,n = 4,24), allowing, however, post-hoc comparisons. As shown in Fig. 3 , there was a signiWcant decrease of NR1 + cell number in substantia nigra of AS (»57%) and AN (»65%) versus CS cultures (Fig. 3a) . A signiWcant decrease was observed in neocortex of AS (»41%), but not of AN cultures. However, a signiWcant decrease was also observed in neocortex of CN (»46%) cultures (Fig. 3c) . Although no diVerences of NR1 + soma size were observed among the experimental groups, the largest NR1 + cells were observed in neocortex (25-28 m), the smallest NR1 + cells in neostriatum (12-14 m), and medium soma sized cells in substantia nigra (16-22 m) . No statistically signiWcant diVerences were observed regarding NR1 + neurite length, among any of the experimental groups.
While TH + plexuses and Wbres were observed in all regions, TH + soma were only observed in the substantia nigra, with bipolar or multipolar features and variably developed dendrite trees, as shown in Figs. 4 and 5. Several types of TH + neurons were observed in all cultures conditions. TH + neurons with big (»28 m), medium (»18 m) and small (»9 m) soma size were observed, but medium-sized TH + neurons were predominant (Fig. 4) . Rich TH + neuritic trees could be seen, extending processes to diVerent planes forming dense networks, probably representing target regions, as exempliWed by a culture from the AS group (Fig. 4a, d) . Figure 5 shows TH + cells of cultures from CS (a,d), AS (b,e), and AN (c,f) rats. A decrease in the amount of TH + neurons, as well as in neurite length, was observed in AS compared to CS culture, but not in AN; The quantitative and multiple comparison analysis (CS, n = 16-19; CN, n = 8-13; AS, n = 17-19; AN, n = 12-13) revealed signiWcant diVerences between groups for cell number (cells/mm 2 ) and neurite length, allowing post-hoc comparisons (H = 10.58; H = 10.93, m,n = 4,32, respectively). As shown in Fig. 6 , there was a statistically signiWcant decrease of TH + cell number in AS (»65%) and AN (»62%), compared to CS cultures. The estimation of neurite length was restricted to that observed in the substantia nigra, where a one-by-one characterization was easily done regarding individually labelled neurons. It was found that neurite length was decreased in AS (»55%), but not in AN cultures, compared to that observed in CS cultures.
Many nNOS + cells were seen in all cultures and regions, with bipolar or multipolar features. The largest number of nNOS + cells/mm 2 was observed in neocortex, and the lowest in substantia nigra. Figure 7 illustrates nNOS + cells found in neostriatum of an AS culture, with medium (18-28 m) soma size. Figure 8 shows microphotographs illustrating nNOS + cells found in substantia nigra of CS (a,b) and AS (c,d) cultures.
The quantitative and multiple comparison analysis (CS, n = 11-13; CN, n = 6-7; AS, n = 7-9; AN, n = 9) 2 ) than that observed in substantia nigra (»6 cells/mm 2 ). Furthermore, in CS cultures, nNOS + soma size was larger in neocortex (36 § 1 m) than in neostriatum (26 § 2 m) or substantia nigra (28 § 2 m) (Fig. 9) .
The number of nNOS + cells/mm 2 was signiWcantly increased in substantia nigra (greater than Wvefold), but decreased (»70%) in neostriatum of AS, compared to CS cultures. While the number of nNOS + cells/mm 2 was also increased in the substantia nigra of AN cultures (greater than fourfold), there was no decrease in neostriatum of AN cultures. Furthermore, compared to CS cultures, nNOS + neurite length was decreased (»40%) in neostriatum of AS, but not in neostriatum of AN cultures (Fig. 9) , suggesting that nicotinamide prevented the eVect of perinatal asphyxia on nNOS + cell number and neurite length observed in that region. No signiWcant diVerences were observed in neocortex, despite an apparent decrease of nNOS + neurons/mm 2 , when comparing AS with CS cultures.
Discussion
We have investigated the potential neuroprotection of nicotinamide on the consequences of perinatal asphyxia on several neuronal parameters assessed in organotypic cultures, including neurite atrophy and neuronal loss, eVects reported by several in vivo (Chen et al. 1997a, b; Kohlhauser et al. 1999a, b) and in vitro (Morales et al. 2003; Klawitter et al. 2005 ) studies, mainly aVecting dopaminergic systems.
Perinatal asphyxia produced a region-speciWc decrease of cell viability in vitro, aVecting substantia nigra, showing above 30% increase in EthD-1 + cells. However, no such eVect was seen in neostriatum or neocortex. Immunocytochemistry conWrmed the vulnerability of the substantia nigra, demonstrating that there was a signiWcant decrease of cells with a neuronal phenotype (by »50%), as assayed with an antibody against the NR1 subunit of the NMDA receptor, considered as a universal marker for neuronal phenotype (Petralia et al. 1994 ). This may include DA neurons. In agreement, there also was a signiWcant decrease in the number of TH + cells/mm 2 following perinatal asphyxia (>50%), as well as a decrease of the length of TH + processes, suggesting neurite atrophy. Surprisingly, following perinatal asphyxia, there was an increase in the number of nNOS + cells/mm 2 in substantia nigra (greater than fourfold), but a decrease in neostriatum (>60%), and no apparent changes in neocortex. The main eVect of nicotinamide was on striatal nNOS + cells, preventing the decrease of the number of nNOS + cells and neurite length produced by perinatal asphyxia. Nicotinamide also prevented the eVect of perinatal asphyxia on TH + neurite length. The present study addresses several important issues related to the eVect of perinatal asphyxia. While the immediate eVects of energy failure are related to functional impairment of pre-existing proteins (e.g. phosphorylation-and redox-related proteins), the long-term eVects are related to alteration of gene expression, as shown by several reports (Dell'Anna et al. 1995; Labudova et al. 1999; Mosgoeller et al. 2000; Lubec et al. 2002) , altering cell survival and neuritogenesis when oxygenation is re-established. Cell vulnerability depends upon the developmental stage of the particular neuronal system. Thus, while the number of dopaminergic cells in the substantia nigra is already established at birth (Olson and Seiger 1972; Loizou 1972; Seiger and Olson 1973; Voorn et al. 1988) , there are, in vivo, waves of naturally occurring active postnatal DA neuron death (Oo and Burke 1997) , therefore increasing the susceptibility of surviving neurons to energy failure, producing, as reported here, a decrease in the number of DA neurons/mm 2 . Furthermore, although DA Wbres invade the neostriatum before birth (Seiger and Olson 1973) , a mature targeting is only achieved postnatally, when patches are replaced by a diVuse DA innervation pattern (Antonopoulos et al. 2002) . The explanting procedure re-establishes the pattern of innervation to a primitive stage, forcing neurites to look for the corresponding targets, until plexuses with a patching appearance are established. The decrease of neurite length reported here perhaps reXects an impaired guidance by neighbouring cells rather than a deWcit of intrinsic growth. It can be speculated that TH + neurite growth is aVected by the observed increase of nNOS + cells/mm 2 locally in the substantia nigra, competing for guidance molecules provided by co-cultured regions. Indeed, it has been previously shown that there is an intriguing point-topoint synaptic interaction between nNOS + and TH + neurons and processes in substantia nigra (HerreraMarschitz et al. 2000) , and ventral striatum and cingulate cortex (Gomez-Urquijo et al. 1999) , providing a morphological basis for a reciprocal interaction between dopamine and NO releasing neurons (Zhu and Luo 1992; West et al. 2002) . Ezquer et al. (2006) have recently reported an increase of nNOS expression in substantia nigra of rats exposed to neonatal hypoxia and reoxygenation. They suggested an inXammatory mechanism, mediated by tumoral necrosis factor-(TNF-) and NO generation by astrocytes through activation of the three NOS isoforms, nNOS, iNOS and endothelial NOS, as previously suggested (Cheng et al. 1994; Schauwecker et al. 1998) . The decrease of nNOS + cells/mm 2 observed in neostriatum has also been reported by others, although this issue has been a subject of debate. Thus, Jiang et al. (1997) reported a reduction of NOS activity in neostriatum and other areas of the brain, but not in neocortex. In contrast, Peci-Saavedra and co-workers Loidl et al. 1997) , using nicotinamide adenine dinucleotide phosphate diaphorase (NADPH-d) as a histochemical marker for NO synthesizing neurons, reported that striatal neurons expressing NADPH-d showed a signiWcant increment in soma size and dendrite length following subsevere and severe asphyxia , as well as an increase of NADPH-d activity in blood vessels of striatal and cortical regions . In agreement, it has been shown in a gene hunting study, using subtrac- tive hybridization that NOS is about threefold upregulated in brain of rat pups exposed to perinatal asphyxia (Labudova et al. 1999 ; see also Lubec et al. 1999) .
In the present study nicotinamide showed no eVect on cell viability tested in vitro, nor on any other parameters measured in the substantia nigra, apart from an increased length of TH + neurites. A modest increase of NR1 + cells/mm 2 was only observed in neocortex. However, a robust eVect was observed in neostriatum, where the number of nNOS + cells/mm 2 was increased greater than fourfold in cultures from nicotinamide-treated, versus saline-treated, asphyxiaexposed animals, which was accompanied by an increase of nNOS + neurite length to control levels. There was a signiWcant decrease in soma size of nNOS + cells in substantia nigra of cultures from AN animals, an eVect diYcult to be explained, but perhaps related to inhibition of inXammatory signals (Koh et al. 2004) .
The eVect of nicotinamide on TH + neurites is in agreement with a recent report showing that the treatment prevents the asphyxia-dependent decrease of dopamine release monitored with in vivo microdialysis 3 months after birth .
Nicotinamide has been shown to protect against oxidative stress (Yan et al. 1999; Wan et al. 1999) , ischemic injury and inXammation (Ducrocq et al. 2000; Sakakibara et al. 2000) in neonatal rat brain, by restoring NADH/NAD + depletion (see Maynard et al. 2001 ), but also by inhibiting PARP-1 overactivation (Zhang et al. 1995; see Virag and Szabo 2002) .
Upon re-oxygenation, there is a cascade of biochemical events worsening the biological outcome elicited by a deWcient metabolism. One of the biochemical events involves the PAR polymerase family, which is activated, whenever there is a risk for DNA damage. Indeed, the polymerase isoforms, PARP-1 and PARP-2, are immediately activated when the integrity of the genome is menaced and/or damaged (Kihara et al. 1994; Akhter et al. 2001; Amé and Spenlehauer de Murcia 2004) . PARP-1 catalyzes the attachment of chains of PAR to a variety of nuclear proteins, including PARP-1 itself. When DNA damage is mild, PARP-1 is involved in the maintenance of chromatin integrity (de Murcia and Menissier de Murcia 1994; Ying et al. 2005) . Excessive activation of PARP-1 leads, however, to NAD + exhaustion and energy crisis (Berger 1985) , and to a caspase-independent apoptosis, via translocation of AIF to the nucleus, initiating nuclear condensation (Jiang et al. 1996; Yu et al. 2002; Hong et al. 2004) . In agreement, we have reported that perinatal asphyxia leads to delayed neuronal death, mainly aVecting neostriatum and neocortex (Dell'Anna et al. 1997 ).
The strongest evidence for the hypothesis that PARP-1 inhibition can constitute a target for neuroprotection following hypoxic or ischemic insults is from Fig. 9 QuantiWcation of number (cell/mm 2 ), soma size ( m), and neurite length (maximum length, m) of nNOS + neurons in: substantia nigra (SN); neostriatum (Str), and neocortex (Cx) of organotypic triple cultures from saline-treated, caesarean-delivered (CS; opened bars, n = 11-13); nicotinamide-treated, caesareandelivered (NC; grey bars, n = 6-7); saline-treated, asphyxiaexposed (AS; Wlled bars, n = 7-9), and nicotinamide-treated, asphyxia-exposed (AN; hatched bars, n = 9) animals. Multiple comparison analysis (Kruskal-Wallis's ANOVA, H) revealed signiWcant diVerences between groups for cell number and soma size (H = 39.54; H = 44.25, m,n = 4,44, respectively), allowing post-hoc comparisons. There was a signiWcant increase of the number of nNOS + cells in SN of cultures from AS and AN animals. In contrast, there was a signiWcant decrease in the number of nNOS + cells in Str of cultures from AS animals. That decrease was prevented in Str of cultures from AN animals. There was a signiWcant decrease in soma size of nNOS + cells in SN of cultures from AN animals. nNOS + neurite length was decreased in Str of cultures from AS, but not from AN animals. The data are means § SEM; *P < 0.05 (Dunn's test) studies showing that the outcome of ischemic injury is decreased in PARP(-/-) mice (Eliasson et al. 1997) , supporting previous evidence that PARP inhibitors, with increasing degrees of potency, decrease brain damage and improve the neurological outcome of perinatal brain injury (Zhang et al. 1995; Ducrocq et al. 2000; Sakakibara et al. 2000) . While nicotinamide has been proposed to protect against brain injury (Yan et al. 1999; Wan et al. 1999; Sakakibara et al. 2000; Ducrocq et al. 2000) , its usefulness has been challenged because of its low potency, limited cell uptake and short cell viability, stimulating the investigation for more speciWc compounds inhibiting PARP-1 overactivation (Takahashi et al. 1999; Ducrocq et al. 2000; Abdelkarim et al. 2001; Kamanaka et al. 2004; Iwashita et al. 2004; Nakajima et al. 2005 ).
The present results support, however, the idea of nicotinamide as an interesting molecule. Nicotinamide pharmacodynamic properties can provide advantages over more selective compounds, in particular its low potency to inhibit PARP-1. This quality can be useful when the compound is administered to developing animals, because the drug will only antagonise the eVect of PARP-1 overactivation, without impairing DNA repair and cell proliferation. Furthermore, nicotinamide can constitute a lead for exploring compounds with similar pharmacological proWle.
In conclusion, nicotinamide prevents long-term neuronal deWcits induced by perinatal asphyxia, mainly observed in neostriatum, on NOS + neurons, but also on TH + neurite growth. The eVect of nicotinamide enlightens the enzyme PARP-1 as a novel target for neuroprotection following insults involving energy failure.
